Identifying delirium in Parkinson’s: evaluation of existing tools and measures
Objective: To evaluate the diagnostic accuracy of tools to identify delirium in inpatients with Parkinson’s disease (PD). Background: Delirium is a serious acute state of…D-penicillamine induced myasthenia gravis – the possible complication of Wilson’s disease treatment.
Objective: D-penicillamine (DPA) belongs to the most frequently used drugs in Wilson’s disease (WD) treatment. Despite the effectiveness in WD treatment, DPA could be involved in many…A Comparison of Cervical Dystonia in Parkinson’s Disease and Idiopathic Isolated Cervical Dystonia
Objective: To perform a prospective analysis of the prevalence and clinical characteristics of cervical dystonia in Parkinson’s disease (CD-PD) and compare these features to those…MRI morphometry and regional hypometabolism in the clinical predominance-types of Progressive Supranuclear Palsy
Objective: To compare brain MRI morphometry and regional hypometabolism among the clinical predominance-types of Progressive Supranuclear Palsy. Background: Recently, MDS-PSP criteria for the clinical diagnosis…The impact of mild cognitive impairment on functioning in people with Parkinson’s disease
Objective: To understand the experience of mild cognitive impairment (MCI) in people with Parkinson’s disease (PwP) and its impact on daily life. Background: Parkinson’s disease…Alterations in Cortico-basal ganglia Directed Connectivity in Parkinsonism and during Therapeutic STN DBS
Objective: Characterize the changes in oscillatory activity and connectivity in the basal ganglia thalamocortical (BGTC) network after induction of parkinsonian and during therapeutic deep brain…Botulinum toxin-A in head and upper extremities tremor. A hand-made option
Objective: This was a 24-week open-label study to assess the role of BoNT-A injections for various types of hand and head tremor Background: Focal treatment…The Impact of Diabetes Mellitus on Motor and Non-Motor Symptoms of Parkinson’s Disease: A Cross-Sectional Study.
Objective: To evaluate the impact of Diabetes Mellitus on the clinical characteristics and symptoms of Parkinson's Disease. Background: Parkinson's disease (PD) is a prevalent neurodegenerative…Levodopa Carbidopa Intestinal Gel for Parkinson’s Disease over 11 years: A Single Center “Real-World” Experience
Objective: To review long-term real-world experience and clinical outcomes in PD patients with LCIG therapy over 11 years in a multidisciplinary University clinic setting. Background:…Determinants of quality of life and daily mobility in Parkinson’s disease: the role of fear of falling.
Objective: We aimed to investigate the relationship between the PD clinical features, the presence of FOF and its impact on QoL. We explored whether the…
- « Previous Page
- 1
- …
- 35
- 36
- 37
- 38
- 39
- …
- 186
- Next Page »